NCT06085300

The Relationship Between Child Language Proficiency and Language of Treatment on the Outcomes of Bilingual Children with Developmental Language Disorder

Recruiting now NA Last updated 14 January 2025

What this trial tests

NA trial testing Sentence recast in Developmental Language Disorder in 120 participants. Currently enrolling.

Timeline

8 August 2023

Primary endpoint
1 May 2028

1 May 2028

Quick facts

Lead sponsor	University of Houston
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	120
Start date	8 August 2023
Primary completion	1 May 2028
Estimated completion	1 May 2028
Sites	1 location across United States

Drugs / interventions tested

• Sentence recast

Conditions studied

• Developmental Language Disorder — all drugs for Developmental Language Disorder →
• Language Impairment — all drugs for Language Impairment →

Sponsor

University of Houston

Who can join

Adults 4 to 6, any sex, with Developmental Language Disorder or Language Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Of the 12 million children in the USA growing up bilingual, about 1 million experience Developmental Language Disorder (DLD), a disorder in language learning and use. Currently there is no guidance for speech language pathologists (SLPs) as to the language of intervention for bilingual children with DLD with differing degrees of proficiency with English or Spanish. This project will examine the relationship between relative language proficiency and the language of intervention, considering monolingual intervention in English and Spanish and bilingual intervention presented by alternating English and Spanish treatment sessions with the goal of improving language outcomes and thereby strengthening long-term academic achievement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.